Account Accounts payable Account Description Balance* $ 21,000 Accounts receivable Accumulated amortization, patent 67,800 51,000 Accumulated depreciation, equipment 149,400 63,000 3,600 4,200 29,400 Accumulated depreciation, vehicles Advertising payable Allowance for doubtful accounts Cash Common shares, 100,000 shares authorized; 25,000 shares were issued at an average price of $10.20%; market price per share on March 31, 2020, was $11.40 Equipment Income tax payable Notes payable** Patent Prepaid rent Retained earnings Unearned revenues Vehicles *Assume that all accounts have normal balances. **$66,000 of the notes payable will be paid by March 31, 2021. Required: ? 474,000 55,800 150,000 115,800 55,800 ? 28,200 82,200 Using the information from the alphabetized post-closing trial balance above, prepare a classified balance sheet for Sassy Pharmaceuticals Inc. as at March 31, 2020. (Enter all amounts as positive values. Enter the balance sheet items in the order of liquidity.) Current assets Total current assets Property, plant and equipment Total property, plant and equipment Intangible assets Total assets SASSY PHARMACEUTICALS INC. Balance Sheet March 31, 2020 Assets Liabilities Current liabilities Liabilities Total current liabilities Non Current liabilities Total liabilities Contributed capital Total equity Total liabilities and equity Equity Analysis Component: 1. What percentage of the assets is financed by debt? (Round the final answer to 2 decimal places.) Asset financed by debt % 2. What percentage of the assets is financed by equity? (Round the final answer to 2 decimal places.) Asset financed by equity %